News

Johnson & Johnson Beats Earnings Estimates. Financial Chief Says It Can Do Any Deal It Wants.
The drug and medical device maker Johnson & Johnson kicked off the healthcare earnings season with a better-than-anticipated ...
Johnson & Johnson beats profit estimates on strong Darzalex, medtech sales
Johnson & Johnson raised its full-year sales forecast on Wednesday after beating estimates for second-quarter profit on ...
Johnson & Johnson’s stock rallies after an earnings beat and raised outlook, lifting pharma stocks
Adjusted earnings per share for the quarter to June 29 fell to $2.77 from $2.82 in the same period a year ago, and topped the average analyst EPS estimate compiled by FactSet of $2.68.
Johnson & Johnson: Q2 Earnings Snapshot
Johnson & Johnson expects full-year earnings in the range of $10.80 to $10.90 per share, with revenue in the range of $93.2 billion to $93.6 billion. This story was generated by Automated Insights ( ...